Kaye I. Foster-Cheek, Director at AGIOS PHARMACEUTICALS INC (AGIO), sold 18,000 shares at $92.62 ($1.7M) on 2018-06-14, disclosed to the SEC on 2018-06-18.
Open-market sale of $1.7M AGIO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $92.62 | 2,181 | $202K | 12.0% |
| 2 | $92.62 | 2,181 | $202K | 12.0% |
| 3 | $93.78 | 5,980 | $561K | 33.3% |
| 4 | $93.78 | 5,980 | $561K | 33.3% |
| 5 | $94.30 | 839 | $79K | 4.7% |
| 6 | $94.30 | 839 |
| $79K |
| 4.7% |
| Total | $93.55 avg | 18,000 | $1.7M | 100% |
| Filing → |
| AGIO | SELL | 2023-08-11 | $649K | — | Filing → |
| AGIO | SELL | 2018-03-21 | $557K | — | Filing → |
| ONXX | SELL | 2013-08-08 | $1.2M | — | Filing → |